Premier Synthetics schedules Q4FY26 board meet on May 20

Premier Synthetics Limited has scheduled a board meeting to discuss its financial performance for the fourth quarter and the fiscal year 2026. The meeting is set to take place on May 20, 2026, in accordance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations.

The primary agenda for the upcoming meeting is the consideration and approval of the audited standalone financial results for the quarter and financial year ended March 31, 2026. Additionally, the board will consider the recommendation of a dividend, if any. This disclosure ensures that shareholders and the market are informed about the company's operational performance during the specified period.

Meeting Details

The following table outlines the key details regarding the scheduled board meeting:

Event	Date
Board Meeting Date	May 20, 2026
Financial Period	Q4FY26
Regulation	Regulation 29

The company has stated that the trading window for dealing in the securities of the company remains closed for all designated persons and their immediate relatives from April 1, 2026, until 48 hours after the declaration of the financial results. The outcome of the board meeting will be disseminated to the stock exchanges immediately after the conclusion of the proceedings. Investors are advised to refer to the official filings for the detailed financial figures once they are released.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+1.40%	-6.77%	-2.10%	-37.17%	-24.74%	-3.99%

Premier Synthetics Limited has filed its quarterly compliance statement with BSE Limited, confirming no deviation in the utilization of proceeds from its Initial Public Offer (IPO) for the quarter ended 31st March, 2026. The submission was made on 10th April, 2026, in accordance with Regulation 32(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Regulatory Compliance Statement

The company has formally confirmed that there have been no deviations or variations in the use of public issue proceeds raised from its IPO. This statement was submitted pursuant to SEBI Circular No. CIR/CFD/CMD1/162/2019 dated 24th December, 2019, demonstrating the company's commitment to regulatory transparency and compliance.

Share Capital Structure Remains Unchanged

Premier Synthetics has maintained a stable share capital structure over the last three financial years. The company provided detailed confirmation regarding various corporate actions:

Corporate Action:	Status
Buy Back of Securities:	No securities bought back
Sweat Equity Shares:	No sweat equity shares issued
Bonus Shares:	No bonus shares issued
Public Issue/Right Issue/QIP:	No such issues undertaken
Employee Stock Option Plan:	No stock option scheme provided

Regulatory Framework Applicability

The company has clarified that Regulation 32 of SEBI (LODR) Regulations, 2015, which pertains to the Statement of Deviation or Variation for proceeds of Public Issue, Right Issue, Preferential Issue, and QIP, is not applicable to the company given its current corporate structure and activities.